Your Cart


Ex Tax: $0.00
  • Stock: In Stock
  • Brand: Cipla Limited
  • Product Code: Erlocip
  • SKU: Erlocip
  • Salt Composition: Erlotinib

Available Options


  - ERLOCIP contains the active substance erlotinib and it is used to treat cancer by inhibiting the activity of the protein called the epidermal growth factor receptor (EGFR)., which  is involved in the growth and spread of cancer cells.

  - ERLOCIP is intended for the treatment of adults only.



  - ERLOCIP is intended for the treatment of adultswith the diagnosed  non-microcirculation  lung carcinoma in an advanced stage. 

  - You can be prescribed as an initial therapy or as therapy after initial chemotherapy if the disease after it remained largely unchanged,

  - This medicine can also be prescribed in combination with another medicine called gemcitabine, if you have pancreatic cancer in the metastatic stage.


Warnings and Precautions:

 - Before starting the use ERLOCIP inform your doctor if you are using:

 - Medicines that can effect  on the change of  the  concentration of erlotinib in blood , like: ketoconazole,  erythromycin, clarithromycin, phenytoin, barbiturates, rifampicin, ciprofloxacin, omeprazole  or protease inhibitors

 - In some cases, these drugs may reduce the efficacy of the drug threfeore a doctor will avoid treatment with these medicines while you are taking  ERLOCIP.

 - Anticoagulants like warfarin, because the drug ERLOCIP may increase the prevalence of bleeding.

 - Statins- cholesterol-lowering medicines

 - Contact lenses and / or have previously had eye problems such as dry eyes, inflammation or ulceration  on the front of the eye.



   - Taking  ERLOCIP with food and drinks?

   - Do not take a drug with food.

   - Pregnancy, breastfeeding and fertility?

   - Avoid pregnancy and breastfeeding while taking the drug ERLOCIP.

   - Vehicle handling and machine handling: it is unlikely that the therapy will affect these abilities.


How to take the drug ERLOCIP?

  - The tablet should be taken at least one hour before or two hours after a meal.

  - The usual dose is one tablet of 150 mg every day if you suffer from non-microcellular lung cancer.

  - The usual dose is one tablet of 100 mg every day if you have metastatic carcinoma of pancreas.

  - ERLOCIP is used in combination with a drug of gemcitabine.

  - Your doctor can adjust the dose gradually, for 50 mg each.

  - For the application of different dosing regimens, ERLOCIP is available in strengths of 25 mg, 100 mg and 150 mg.



-Stomach ulcer or diverticulosis   

 - Impaired liver function

·         - Infection

·         - Loss of appetite and weight loss

·         - Depression

·         - Headache, changed skin sensitivity, extremity limb

·         - Breathing difficulties, cough

·         - Nausea

·         - Irritation of the mouth

·         - Pain in the stomach, difficulty digestion

·         - Itching, dry skin and hair loss·

·         - Fatigue, fever (fever), stiffness·

·         - Bleeding from the nose, the stomach or intestine

 • Cracked skin (fissures on the skin)

 -  Reduced renal function Rare side effects (can occur in up to 1 in 1000 patients taking the drug):

 -  Redness and painful sensitivity of the palms or feet  Cases of damage to the cornea (perforation or ulceration of the cornea)·

 -  Bstering and skin peeling (indicating Stevens-Johnson syndrome)

·         -   Proliferation and vomiting

·         -   Persistent and severe diarrhea

·         -   Eye irritation due to conjunctivitis / keratoconjunctivitis.

Write a review

Note: HTML is not translated!
Bad Good